With expiration looming for its $3.6B offer to buy painkiller specialist King Pharmaceuticals...

|About: King Pharmaceuticals Inc. (KG)|By:, SA News Editor

With expiration looming for its $3.6B offer to buy painkiller specialist King Pharmaceuticals (KG +0.7%), Pfizer (PFE) extends the offer again, until midnight Jan. 28. About 115.3M King shares have been tendered - still about 46.6% outstanding, but the sum is down from last month's 116.5M.